Testing a drug and exercise for heart and muscle fat in diabetes
Part of Hormones & metabolism clinical trials.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 75 years old
- You have type 2 diabetes diagnosed within the last 10 years and are not on insulin
- Your HbA1c (a measure of blood sugar) is 7% or higher
- You get less than 150 minutes of moderate-to-vigorous activity per week (like brisk walking or cycling)
- Your body mass index (BMI) is 27 or higher, and you weigh less than 140 kg (about 308 pounds)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
This study tests a new weekly injection (called NNC0487-0111) against an existing medicine (semaglutide) to see if it helps people with type 2 diabetes lose more weight. Together with standard diabetes care and lifestyle changes, you would receive the study medicine for about a year, and the study team will monitor your health and weight.
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests whether weight loss from a medication can improve how you feel, move, and how well your heart works. It's for people who have both obesity and heart failure with reduced pumping strength.
Hear when a new Diabetes Mellitus Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.